Taurodeoxycholic acid
|
Basic information |
| Metabolite name | Taurodeoxycholic acid |
 | HMDB0000896 |
 |
C05463 |
 |
2733768 |
| Synonyms | NA |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Taurodeoxycholic acid |
| HMDB0000896 |
|
C05463 |
|
2733768 |
| Synonyms | NA |
| No. of studies | 6 |
|
Relationship between Taurodeoxycholic acid and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Up |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Faece | BALB/c mouse | Down |
| Study M847 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Up |
| Study M912 | Type1 | CUMS group vs. control group | Faece | ICR mouse | Up |
| Study M912 | Type1 | CUMS group vs. control group | Liver | ICR mouse | Up |